Navigation Links
Peer-Reviewed Study Published on Active Noise Control Device in Simulated NICU
Date:7/18/2020

A study has been published in the journal PLOS ONE that demonstrates the effectiveness of the Invictus Medical Neoasis™ active noise control device to attenuate typical noises in a simulated neonatal intensive care unit (NICU) environment. The study reported that the Neoasis™ device attenuated the alarm sounds from patient monitors, ventilators and other bedside devices that would affect the infants cared for in incubators.

“The problems associated with the effect of NICU noise on the incubated preemie patient are documented in the literature in terms of sleep and weight gain, and effective solutions remain elusive.” said George Hutchinson, Invictus Medical’s Chief Executive Officer. “We are optimistic that this bench-top study foretells a great means of protecting these vulnerable patients.”

The greatest attenuation achieved was 14.4 decibels for a typical patient monitor alarm, equating to a 5.5-fold decrease in sound pressure level that the incubator-oriented patient would experience. The study was conducted in the simulation center of the Children’s Hospital of San Antonio, supported by the simulation center’s staff. The results of the study are available at https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0235287.

The Neoasis™ is still in development and is not currently being distributed.

About Invictus Medical
Invictus Medical is a San Antonio, Texas-based medical device company that aims to ensure that children are able to attain their developmental milestones. As evidenced by their record of National Science Foundation and National Institutes of Health grants, Invictus Medical has been at the forefront of pediatric care since its founding in 2012. Invictus Medical is a privately held company. For more information about Invictus Medical, please see http://www.invictusmed.com.

Read the full story at https://www.prweb.com/releases/peer_reviewed_study_published_on_active_noise_control_device_in_simulated_nicu/prweb17255755.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related biology news :

1. 3-D Printing and Additive Manufacturing: Preview issue of groundbreaking peer-reviewed journal now available
2. Peer-reviewed paper says all ivory markets must close
3. Peer-Reviewed Paper in Frontiers in Bioengineering and Biotechnology Reveals that uBiome Has the Largest Patent Portfolio in the Microbiome Space
4. Rescue me: New study finds animals do recover from neglect
5. Study led by NUS scientists reveals escalating cost of forest conservation
6. BUSM study reveals novel mechanism by which UVA contributes to photoaging of skin
7. Monoclonal Antibody with Xencors High ADCC Fc Technology Enters Phase 2 Study in B-cell Acute Lymphoblastic Leukemia
8. University of Houston engineering professor awarded grant to study melanoma treatment
9. Study examines effects of genetic variants for infants with neonatal abstinence syndrome
10. Zebrafish study suggests that vitamin B2 (riboflavin) is an antidote to cyanide poisoning
11. Study finds possible alternative to bariatric weight loss surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2020)... ... 2020 , ... In an upcoming episode scheduled for the fall of 2020, ... solutions (POCT). Check local listings for more info. , Today, the majority of testing ... to labs throughout the country. Results are then available several days later. Now, in ...
(Date:6/23/2020)... ... June 23, 2020 , ... ... to announce the next event in a series of TOPIQ webinars, which will ... series of webinars was developed in response to social distancing measures that resulted ...
(Date:6/13/2020)... ... 2020 , ... Bode Technology (Bode), a leading ... team. Bode’s Forensic Genealogy Service (FGS) continues to deliver investigative leads ... The team has added experienced genealogists, each having over a decade of field ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... ... July 17, 2020 , ... dicentra , ... sciences and food industries, is pleased to announce that Charles Galea has joined ... Development. , Charles is an accomplished and results-driven sales executive with over 10 ...
(Date:7/10/2020)... ... 2020 , ... Sentien Biotechnologies, Inc., a clinical-stage biotechnology company ... Nissenson, M.D., F.A.C.P., as its Chief Medical Officer. Dr. Nissenson will join ... Dr. Nissenson serves as an Emeritus Professor of Medicine at the David ...
(Date:7/1/2020)... ... June 29, 2020 , ... The ... purchasing contracts to its membership, recently named BioFit Engineered Products an ... opportunity to purchase ergonomic seating, cafeteria tables, book trucks and carts at discounted ...
(Date:6/28/2020)... HILL, Conn. (PRWEB) , ... June 25, 2020 ... ... company formed to advance photodynamic therapy for treating cancer, today announced the company ... New York (“Roswell Park”). The agreement provides Lumeda globally exclusive rights to ...
Breaking Biology Technology: